Duopharma Biotech Berhad (KLSE:DPHARMA)

Market Cap	1.14B
Revenue (ttm)	813.70M
Net Income (ttm)	62.65M
Shares Out	961.94M
EPS (ttm)	0.07
PE Ratio	18.12
Forward PE	13.14
Dividend	0.03 (2.50%)
Ex-Dividend Date	Mar 5, 2025

Volume	40,500
Average Volume	189,160
Open	1.190
Previous Close	1.200
Day's Range	1.180 - 1.190
52-Week Range	1.070 - 1.450
Beta	0.77
RSI	48.62
Earnings Date	May 16, 2025

About Duopharma Biotech Berhad

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products comprising vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides ...

• Industry: Pharmaceutical Preparations
• Founded: 1978
• Employees: 1,957
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: DPHARMA

Financial Performance

In 2024, Duopharma Biotech Berhad's revenue was 813.70 million, an increase of 15.46% compared to the previous year's 704.73 million. Earnings were 62.65 million, an increase of 19.00%.